Broderick Brian C Abb Vie Inc. Transaction History

Broderick Brian C

$453 Million
Q2 2024

A detailed history of Broderick Brian C transactions in Abb Vie Inc. stock. As of the latest transaction made, Broderick Brian C holds 13,123 shares of ABBV stock, worth $2.55 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

13,123

Previous 12,612 4.05%

Holding current value

$2.55 Million

Previous $2.3 Million 2.0%

% of portfolio

0.5%

Previous 0.53%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $79,097 - $92,368	511 Added 4.05%	13,123 $2.25 Million
Q1 2024 May 03, 2024	BUY	$159.82 - $182.1 $267,378 - $304,653	1,673 Added 15.29%	12,612 $2.3 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $173,100 - $194,952	-1,258 Reduced 10.31%	10,939 $1.7 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $9,351 - $10,825	-70 Reduced 0.57%	12,197 $1.82 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $10,122 - $11,657	-70 Reduced 0.57%	12,267 $1.95 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $93,359 - $111,962	-675 Reduced 5.19%	12,337 $2 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $30,197 - $34,634	-225 Reduced 1.7%	13,012 $1.75 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $285,561 - $363,042	-2,075 Reduced 13.55%	13,237 $2.03 Million
Q1 2022 May 17, 2022	SELL	$131.98 - $163.75 $77,868 - $96,612	-590 Reduced 3.71%	15,312 $2.48 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $1,074 - $1,359	-10 Reduced 0.06%	15,902 $2.15 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $6,916 - $7,850	-65 Reduced 0.41%	15,912 $1.72 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $12,625 - $14,065	-120 Reduced 0.75%	15,977 $1.8 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $1,534 - $1,689	-15 Reduced 0.09%	16,097 $1.74 Million
Q3 2020 Oct 28, 2020	BUY	$85.91 - $100.83 $107,988 - $126,743	1,257 Added 8.46%	16,112 $1.41 Million
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $48,424 - $64,798	-660 Reduced 4.25%	14,855 $1.46 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $645 - $977	-10 Reduced 0.06%	15,515 $1.18 Million
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $66,720 - $83,481	-925 Reduced 5.62%	15,525 $1.38 Million
Q3 2019 Nov 04, 2019	SELL	$62.98 - $75.72 $119,662 - $143,868	-1,900 Reduced 10.35%	16,450 $1.25 Million
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $47,632 - $60,885	-725 Reduced 3.8%	18,350 $1.33 Million
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $34,327 - $40,401	-445 Reduced 2.28%	19,075 $1.54 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $72,789 - $89,769	-935 Reduced 4.57%	19,520 $1.8 Million
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $13,336 - $14,826	-150 Reduced 0.73%	20,455 $1.93 Million
Q2 2018 Jul 30, 2018	SELL	$89.78 - $106.23 $67,335 - $79,672	-750 Reduced 3.51%	20,605 $1.91 Million
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $75,448 - $101,032	-820 Reduced 3.7%	21,355 $2.02 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $421,827 - $462,569	-4,710 Reduced 17.52%	22,175 $2.14 Million
Q3 2017 Oct 26, 2017	BUY	$69.85 - $89.22 $1.88 Million - $2.4 Million	26,885	26,885 $2.39 Million

Others Institutions Holding ABBV

# of Institutions

3,699

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.

Account

Broderick Brian C Abb Vie Inc. Transaction History